UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000031587
Receipt No. R000036068
Scientific Title Examination of continuous ingestion of drink containing plant extract. N-18003
Date of disclosure of the study information 2018/03/09
Last modified on 2018/09/03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of continuous ingestion of drink containing plant extract. N-18003
Acronym Examination of continuous ingestion of drink containing plant extract. N-18003
Scientific Title Examination of continuous ingestion of drink containing plant extract. N-18003
Scientific Title:Acronym Examination of continuous ingestion of drink containing plant extract. N-18003
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Cardiology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the effects of plant extract on vascular function and autonomic nerve activity.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Skin temperature.
Key secondary outcomes Peripheral blood flow, subjective evaluation and autonomic nerve activity.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Placebo
Stratification YES
Dynamic allocation NO
Institution consideration
Blocking YES
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Continuous ingestion of drink containing plant extract
Interventions/Control_2 Continuous ingestion of placebo drink not containing plant extract
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
30 years-old >=
Gender Female
Key inclusion criteria 1.Healthy adults
2.Person who agrees not to ingest specified foods and supplements during the test period.
Key exclusion criteria 1.Person whose diastolic blood pressures are more than 90mmHg and systolic ones are more than 140mmHg.
2.Person who has severe allergic disease as rhinitis, atopicdermatitis.
3.Person who is pregnant, lactating or planned to become pregnant during the test period.
4.Patient with vascular function disorder.
5.Person who has problems with electrocardiogram test such as arrhythmia.
6.Person who takes medicine.
7.Person who regularly goes to hospital or went to the medical institution within a month.
8.Current smoker.
9.Person who plans to participate in the other clinical studies.
10.Person who is judged as unsuitable for the study by the investigator for other reasons.
Target sample size 12

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yamamoto Noriyuki
Organization Japanese Red Cross Hokkaido College of Nursing
Division name Department of Health Sciences, Professor
Zip code
Address 1-664 Akebono Kitami Hokkaido
TEL +81-157-66-3390
Email yama@rchokkaido-cn.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yukinori Nakashima
Organization Kao Corporation
Division name R&D-Skin Care Products Research
Zip code
Address 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan
TEL +81-3-5630-9581
Homepage URL
Email nakashima.yukinori@kao.com

Sponsor
Institute Japanese Red Cross Hokkaido College of Nursing
Institute
Department

Funding Source
Organization Kao Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 花王株式会社(東京都)

Other administrative information
Date of disclosure of the study information
2018 Year 03 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 02 Month 23 Day
Date of IRB
Anticipated trial start date
2018 Year 03 Month 12 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 03 Month 05 Day
Last modified on
2018 Year 09 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036068

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.